ResMed | RMD - 流动资产

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 30.55B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	流动资产	更改		日
Ansell	USD 1.11B		5.2M	2025-12
Artivion	USD 357.52M		566K	2026-03
AtriCure	USD 313.69M		8.82M	2026-03
Baxter International	USD 6.85B		25M	2026-03
Cochlear	AUD 1.37B		43.9M	2025-12
Cooper Companies	USD 2.13B		27.4M	2025-12
CSL	USD 11.85B		1000K	2025-12
Dexcom	USD 4.33B		298.4M	2026-03
Edwards Lifesciences	USD 6.23B		510.2M	2026-03
Fisher Paykel Healthcare	NZD 983.7M		48.3M	2025-12
Globus Medical	USD 2.2B		72.51M	2026-03
Haemonetics	USD 834.88M		108.8M	2026-03
Idexx Laboratories	USD 1.45B		40.25M	2026-03
Inogen	USD 203.72M		594K	2025-09
Insulet	USD 1.71B		204.5M	2026-03
Integra LifeSciences	USD 1.17B		12.47M	2026-03
Intuitive Surgical	USD 11.52B		881.5M	2026-03
Masimo	USD 870.5M		55.5M	2026-03
Medtronic	USD 24.07B		75M	2025-12
Philips	EUR 9.78B		148M	2026-03
Ramsay Health Care	AUD 3.56B		480.3M	2025-12
ResMed	USD 4.06B		245.26M	2026-03
Sigma Healthcare	AUD 2.91B		2B	2025-12
Sonic Healthcare	AUD 2.3B		52.76M	2024-12
Steris	USD 2.39B		108.4M	2026-03
Teleflex	USD 1.86B		78.67M	2026-03
Thermo Fisher Scientific	USD 22.32B		6.39B	2026-03